The Irony of Corruption, Too Much Power Given to P
Post# of 148158
(Total Views: 448)
Posted On: 05/19/2021 3:08:15 PM
The Irony of Corruption, Too Much Power Given to People & Agencies
Remdesivir.....revenue 2020 + 2021 = $$$$, leronlimab = zero
Remdesivir.....efficacy = no benefit , leronlimab saves lives
Remdesivir.....side effects = potential organ damage, Leronlimab none
Remdesirir......friends in FDA & Congress = mucho, leronlimab = FDA attacks
Remdesivir.....executive quoted today.....
And then on remdesivir Veklury, there continues to be a need and the product continues to do really well. It’s become standard of care for patients that are hospitalized. We are seeing increased usage outside of the United States as well. And so to the extent that the pandemic continues to have an impact on our base business, it’s largely offset by the fact that Veklury is providing a significant benefit for patients and we will see sales and cash flow from that. So overall, we feel really good about where we are and we are encouraged by the signs that we are seeing recently.
Remdesivir.....revenue 2020 + 2021 = $$$$, leronlimab = zero
Remdesivir.....efficacy = no benefit , leronlimab saves lives
Remdesivir.....side effects = potential organ damage, Leronlimab none
Remdesirir......friends in FDA & Congress = mucho, leronlimab = FDA attacks
Remdesivir.....executive quoted today.....
And then on remdesivir Veklury, there continues to be a need and the product continues to do really well. It’s become standard of care for patients that are hospitalized. We are seeing increased usage outside of the United States as well. And so to the extent that the pandemic continues to have an impact on our base business, it’s largely offset by the fact that Veklury is providing a significant benefit for patients and we will see sales and cash flow from that. So overall, we feel really good about where we are and we are encouraged by the signs that we are seeing recently.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼